Jinwu Financial News | Pharmaceutical stocks are trending strongly, and the Hang Seng Healthcare Index rose 1.34%. Among them, Jingtai Technology's QUANTUMPH-P (02228) rose 21.84%, Yiming Angke (01541) rose 9.94%, Zaiding Pharmaceutical (09688) rose 9.64%, Xianjian Technology (01302) rose 5.22%, Laikai Pharmaceutical (02105) rose 5.52%, and Tiger Pharmaceuticals (03347) rose 5.36%.
Zhongtai International said that since October, the pharmaceutical industry's stock price performance has been divided. Among the constituent stocks of the Hang Seng Healthcare Index, the biotechnology, medical services, and medical device sectors, which were stimulated earlier by interest rate cut policies, have declined. Due to reasons such as the fact that domestic healthcare industry financing data is still poor, the market is worried that it will take some time for the innovative drug sector's business environment to recover, and the pharmaceutical R&D outsourcing service (CXO) sector has also rebounded. The pharmaceutical sector, which has many medium and large mature pharmaceutical companies, has generally experienced a sharp rise in interest rate cuts due to sufficient capital in the early stages, and has been relatively stable recently.
After experiencing policy incentives such as interest rate cuts, the bank believes that the pharmaceutical industry will return to rational investment, and the market will wait and see if the government has more financial support for the pharmaceutical industry in the future. Short-term recommendations focus on companies with strong certainty and sufficient capital for 2024 results.
